Serum Pepsinogens and Helicobacter pylori in Relation to the Risk of Esophageal Squamous Cell Carcinoma in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study
- 1 August 2010
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Epidemiology, Biomarkers & Prevention
- Vol. 19 (8), 1966-1975
- https://doi.org/10.1158/1055-9965.epi-10-0270
Abstract
Background: Helicobacter pylori can induce gastric atrophy in humans, which in turn increases gastric cancer risk. Whether H. pylori and gastric atrophy also affect the risk of esophageal squamous cell carcinoma (ESCC), however, remains unresolved. Methods: We performed a nested case-control study within the prospective Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study to assess these relationships. The Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study is composed of 29,133 Finnish male smokers, ages 50 to 69 years, who were recruited during 1985-1988. Using baseline sera, we assessed H. pylori status (via immunoglobulin G antibodies against whole-cell and CagA antigens) and gastric atrophy status [via the biomarkers pepsinogen I (PGI) and pepsinogen II (PGII)] in 79 ESCC cases and 94 controls. Logistic regression with adjustment for age, date of blood draw, education, cigarette smoking, alcohol, body mass index, and fruit and vegetable intake was used to estimate odds ratios (OR) and 95% confidence intervals (95% CI). Results: Gastric atrophy (PGI/PGII H. pylori and ESCC (OR, 0.94; 95% CI, 0.40-2.24). Conclusions: These results could be explained by misclassification of H. pylori status due to serologic amnesia, ESCC risk being dependent on the functional consequences or interactions of H. pylori rather than the infection per se, gastric atrophy having a different histogenesis in ESCC without being primarily dependent on H. pylori acquisition, or a lack of statistical power to detect an effect. Impact: Validation of these results may warrant mechanistic studies to determine the route of association between gastric atrophy and ESCC. Cancer Epidemiol Biomarkers Prev; 19(8); 1966–75. ©2010 AACR.Other Versions
This publication has 57 references indexed in Scilit:
- Increasing trend of the incidence of esophageal squamous cell carcinoma, but not adenocarcinoma, in TaiwanCancer Causes & Control, 2009
- Oesophageal cancer incidence in the United States by race, sex, and histologic type, 1977–2005British Journal of Cancer, 2009
- Macroscopic extent of gastric mucosal atrophy: increased risk factor for esophageal squamous cell carcinoma in JapanBMC Gastroenterology, 2009
- Serum pepsinogens and risk of gastric and oesophageal cancers in the General Population Nutrition Intervention Trial cohortGut, 2009
- Interactions in Epidemiology: Relevance, Identification, and EstimationEpidemiology, 2008
- Serum pepsinogens and risk of esophageal squamous dysplasiaInternational Journal of Cancer, 2008
- Helicobacter pylori and Esophageal Cancer Risk: A Meta-analysisCancer Prevention Research, 2008
- Trends in oesophageal cancer incidence and mortality in EuropeInternational Journal of Cancer, 2007
- An African origin for the intimate association between humans and Helicobacter pyloriNature, 2007
- Inflammation, atrophy, and gastric cancerJCI Insight, 2006